1. Home
  2. FINV vs MRVI Comparison

FINV vs MRVI Comparison

Compare FINV & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$4.83

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$6.04

Market Cap

902.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
MRVI
Founded
2007
2014
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
902.7M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
FINV
MRVI
Price
$4.83
$6.04
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$12.10
$4.13
AVG Volume (30 Days)
697.6K
3.3M
Earning Date
05-19-2026
05-07-2026
Dividend Yield
6.09%
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
N/A
$12.54
Revenue Next Year
$10.58
$7.87
P/E Ratio
$3.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$1.99
52 Week High
$10.90
$6.55

Technical Indicators

Market Signals
Indicator
FINV
MRVI
Relative Strength Index (RSI) 48.73 68.66
Support Level $4.67 $3.27
Resistance Level $5.23 N/A
Average True Range (ATR) 0.17 0.32
MACD 0.01 0.05
Stochastic Oscillator 49.09 67.91

Price Performance

Historical Comparison
FINV
MRVI

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: